[Purpose] The purpose of this study was to identify the effects of pain scrambler therapy on the pain and quality of life of degenerative gonarthritis patients. [Subject and Methods] This study is a single case study. Pain scrambler therapy was applied for 40 minutes per session once a day for 15 days to a 62-year-old female patient diagnosed with degenerative gonarthritis. Pain was measured using the Visual Analogue Scale and quality of life was measured using the short form-36 item after therapy. [Results] Decrease in pain and improved quality of life were evident after pain scrambler therapy. [Conclusion] Pain scrambler therapy had a potential to decrease pain and improve the quality of life in degenerative gonarthritis patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857462 | PMC |
http://dx.doi.org/10.1589/jpts.30.479 | DOI Listing |
Ther Clin Risk Manag
January 2025
Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.
Non-NF2 schwannomatosis is a rare syndrome characterized by multiple benign schwannomas that primarily affect nerve sheaths, with chronic, treatment-resistant pain as the most common symptom. No protocol has been established for pain management, and pharmacotherapies, including molecular target therapies, are being evaluated. Neuromodulation therapies such as scrambler therapy and surgical options are also employed; however, surgery may lead to persistent or recurrent pain caused by nerve damage or tumor recurrence.
View Article and Find Full Text PDFA A Pract
August 2024
Department of Pain Medicine, Division of Anesthesiology, Critical Care & Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Among the 2 million amputees in the United States, 60% to 90% will experience phantom limb pain (PLP). Managing PLP presents challenges with current evidence-based pharmacological and interventional therapies yielding varied results. In recent years, advancements in neuromodulation, such as scrambler therapy (ST), have demonstrated effectiveness in addressing various chronic and neuropathic pain syndromes.
View Article and Find Full Text PDFAnn Clin Transl Neurol
November 2024
Department of Neurology, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
Objective: Strokes involving sensory pathways can result in contralesional pain syndromes often refractory to pharmacologic interventions. Scrambler therapy (ST) is a noninvasive electroanalgesia device used to treat pain caused by peripheral neuropathy; however, data are scarce regarding its use in conditions secondary to central nervous system pathology. We evaluate the efficacy of ST to treat poststroke pain.
View Article and Find Full Text PDFOcul Surf
October 2024
Division of General Internal Medicine, Section of Palliative Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD, USA.
Cureus
May 2024
Department of Internal Medicine, Shri M.P. (Meghaji Pethraj) Shah Government Medical College, Jamnagar, IND.
Neuropathic pain (NP), arising from dysfunction in the neurological system, poses a significant challenge in pain management due to its intricate origin and unpredictable response to conventional treatments. Electroanalgesia, a collection of techniques such as transcutaneous electric nerve stimulation (TENS), peripheral electrical nerve stimulation (PENS), spinal cord stimulation (SCS), deep brain stimulation (DBS), and electroacupuncture (EA), presents a potential alternative or complementary approach. This review brings together evidence from 56 studies to evaluate the effectiveness and safety of electroanalgesia in chronic NP.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!